11.29
0.13 (1.16%)
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Mixed | Bearish |
Biotechnology (Global) | Mixed | Bearish | |
Stock | Avid Bioservices, Inc. | Bullish | Bearish |
Stockmoo Score
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Core |
Ownership
Name | Date | Shares Held |
---|---|---|
Altravue Capital, Llc | 30 Jun 2024 | 3,395,263 |
Snyder Capital Management L P | 30 Jun 2024 | 1,991,846 |
Coliseum Capital Management, Llc | 30 Jun 2024 | 1,746,588 |
52 Weeks Range | ||
Price Target Range | ||
High | 12.00 (RBC Capital, 6.29%) | Buy |
12.00 (Stephens & Co., 6.29%) | Buy | |
Median | 12.00 (6.29%) | |
Average | 12.00 (6.29%) | |
Total | 2 Buy | |
Avg. Price @ Call | 10.49 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
RBC Capital | 10 Sep 2024 | 12.00 (6.29%) | Buy | 10.49 |
03 Jul 2024 | 8.00 (-29.14%) | Buy | 7.70 | |
Stephens & Co. | 10 Sep 2024 | 12.00 (6.29%) | Buy | 10.49 |
No data within this time range.
Date | Type | Details |
---|---|---|
12 Sep 2024 | Announcement | Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference |
09 Sep 2024 | Announcement | Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 |
03 Sep 2024 | Announcement | Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 |
02 Jul 2024 | Announcement | Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 |
01 Jul 2024 | Announcement | Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |